NCT06607978

Brief Summary

verify Relationship of noninvasive assessment of central arterial blood pressure with 10 years Atherosclerotic Cardiovascular disease (ASCVD) in Subclinical hypothyroidism

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Oct 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2024Dec 2026

First Submitted

Initial submission to the registry

September 19, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 23, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

1.9 years

First QC Date

September 19, 2024

Last Update Submit

September 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assess the extent to which subclinical hypothyroidism is associated with atherosclerotic cardiovascular disease

    the extent to which subclinical hypothyroidism is associated with atherosclerotic cardiovascular disease

    2025

Study Arms (2)

patients with subclinical hypothyroidism admitted to internal medicine department.

patients with subclinical hypothyroidism admitted to internal medicine department.

healthy match individual .

healthy match individual

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Full Personal history will include: Demographic data age, sex, material status, smoking history, residence (rural, urban) ,presence of previous medical disease (DM ,HTN, cardiac ,renal disease). Full medical history will include Duration of the disease, history of treatment intake ,history of autoimmune disease

You may qualify if:

  • Age 18-70
  • Both sex

You may not qualify if:

  • Patients had thyroidectomy operation
  • Patients with a history of encompassing acute coronary syndrome (ACS).
  • Myocardial infarction (MI).
  • Coronary heart disease (CHD).
  • Cerebrovascular diseases or other arterial revascularization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Mohamed Faisal, Doctor

    Dr/ Mohamed Faisal El Adway

    STUDY DIRECTOR

Central Study Contacts

Mona Abdelhameed, Master

CONTACT

Sohair Mostafa, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 19, 2024

First Posted

September 23, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 24, 2024

Record last verified: 2024-09